UTHR

United Therapeutics Corporation (UTHR)

Last Price$365.0(0.4%)
Market Cap$16.2B
LTM ROIC - WACC
63.5%
5Y avg
47.3%
Biotechnology industry median
(127.8%)
Stock quality & Intrinsic value
8/10
0.2% undervalued

United Therapeutics Corporation ROIC - WACC

Annual
Quarterly
LTM
Industry median
Company stand-alone
UTHR
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
ROIC - WACC
22.8%
90.7%
78.8%
3.6%
(34.2%)
2.4%
24.8%
47.3%
46.4%
23.9%
46.1%
34.8%
82.6%
45.5%
54.5%
(15.6%)
37.8%
34.6%
58.0%
57.9%
UTHR
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for UTHR and see if it's the right time to invest.
Dive in

United Therapeutics Corporation (UTHR) ROIC - WACC comparison analysis

Crunching data... Almost there!

UTHR key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is United Therapeutics Corporation's ROIC - WACC?

As of today, Microsoft Corp's last 12-month ROIC - WACC is 63.5%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual ROIC - WACC for United Therapeutics Corporation have been 56.8% over the past three years, and 49.7% over the past five years.

2) Is United Therapeutics Corporation's ROIC - WACC Good?

As of today, United Therapeutics Corporation's ROIC - WACC is 63.5%, which is higher than industry median of (127.8%). It indicates that United Therapeutics Corporation's ROIC - WACC is Good.

3) How does United Therapeutics Corporation's ROIC - WACC compare to its peers?

As of today, United Therapeutics Corporation's ROIC - WACC is 63.5%, which is higher than peer median of (23.7%). The list of peers includes NVO, REGN, GMAB, VRTX, INCY, ALNY, BGNE, BNTX, MRNA, ARGX.